Fundz

Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer

PRIVATEAug 21, 2023

Position

Chief Development Officer

Company

Ray Therapeutics

Jenny Holt
jenny.holt@raytherapeutics.com
San DiegoBiotechnologyHealth CareScience And Engineering

Description

Ray Therapeutics, a leading optogenetics medicines company, today announced the promotion of Jenny Holt to Chief Development Officer.

Quick answer

Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer (August 21, 2023). Ray Therapeutics is based in San Diego, California, United States.

Who is the new Chief Development Officer at Ray Therapeutics?
Ray Therapeutics named Jenny Holt Chief Development Officer, announced August 21, 2023.
What did Ray Therapeutics announce on August 21, 2023?
Ray Therapeutics, a leading optogenetics medicines company, today announced the promotion of Jenny Holt to Chief Development Officer.
What does Ray Therapeutics do?
Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and...
Where is Ray Therapeutics based?
Ray Therapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
The Hain Celestial Group (August 24, 2023), Sydnexis (August 29, 2023), Co-Diagnostics, Inc. (August 29, 2023) and Viracta Therapeutics (August 7, 2023) also announced leadership changes within 45 days of Ray Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ray Therapeutics, and when

A new leader at Ray Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ray Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ray Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ray Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ray Therapeutics

Location

3625 Dudley Street

San Diego, California, United States

About

Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Our studies have shown for the first time that our proprietary ChRown optogenetic protein can restore high levels of visual acuity, contrast sensitivity and visual field. RayTx lead asset, RTx-015, is expected to address the huge unmet medical in people suffering from many forms of retinal blindness (independent of the underlying genetic cause), including those with advanced age-related macular degeneration. RayTx has partnered with a world-leading AAV gene therapy manufacturer is utilizing their proprietary commercial manufacturing process and analytics to maximally de-risk clinical development. RayTx anticipates clinical trials will begin by the end of 2023 in our initial indication, retinitis pigmentosa.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ray Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jerrod
Senior decision-maker at this company
••••••••@••••••••

See Jerrod's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Ray Therapeutics's next move

Learn about Strategic plan

Ray Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.